協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/08/20 | 1,045 | 1,049 | 1,023 | 1,024 | -28 | -2.7% | 1,185,000 |
| 2013/08/19 | 1,052 | 1,059 | 1,044 | 1,052 | +1 | +0.1% | 766,000 |
| 2013/08/16 | 1,057 | 1,065 | 1,033 | 1,051 | -6 | -0.6% | 1,452,000 |
| 2013/08/15 | 1,064 | 1,065 | 1,051 | 1,057 | -8 | -0.8% | 1,680,000 |
| 2013/08/14 | 1,049 | 1,065 | 1,043 | 1,065 | +20 | +1.9% | 1,522,000 |
| 2013/08/13 | 1,015 | 1,046 | 1,015 | 1,045 | +38 | +3.8% | 1,305,000 |
| 2013/08/12 | 1,004 | 1,024 | 997 | 1,007 | -7 | -0.7% | 2,233,000 |
| 2013/08/09 | 1,013 | 1,023 | 1,000 | 1,014 | +13 | +1.3% | 1,651,000 |
| 2013/08/08 | 1,000 | 1,029 | 997 | 1,001 | -6 | -0.6% | 1,306,000 |
| 2013/08/07 | 1,020 | 1,033 | 1,007 | 1,007 | -33 | -3.2% | 1,626,000 |
| 2013/08/06 | 1,034 | 1,041 | 1,014 | 1,040 | +4 | +0.4% | 1,247,000 |
| 2013/08/05 | 1,035 | 1,049 | 1,021 | 1,036 | -2 | -0.2% | 1,030,000 |
| 2013/08/02 | 1,013 | 1,039 | 1,008 | 1,038 | +38 | +3.8% | 1,389,000 |
| 2013/08/01 | 985 | 1,002 | 979 | 1,000 | +22 | +2.2% | 1,835,000 |
| 2013/07/31 | 1,000 | 1,003 | 976 | 978 | -39 | -3.8% | 2,845,000 |
| 2013/07/30 | 1,018 | 1,024 | 1,005 | 1,017 | -18 | -1.7% | 2,269,000 |
| 2013/07/29 | 1,062 | 1,064 | 1,033 | 1,035 | -50 | -4.6% | 1,576,000 |
| 2013/07/26 | 1,104 | 1,122 | 1,070 | 1,085 | -31 | -2.8% | 1,849,000 |
| 2013/07/25 | 1,124 | 1,128 | 1,109 | 1,116 | -5 | -0.4% | 893,000 |
| 2013/07/24 | 1,122 | 1,130 | 1,114 | 1,121 | -11 | -1% | 854,000 |
| 2013/07/23 | 1,116 | 1,134 | 1,114 | 1,132 | +5 | +0.4% | 1,014,000 |
| 2013/07/22 | 1,134 | 1,134 | 1,117 | 1,127 | +11 | +1% | 678,000 |
| 2013/07/19 | 1,135 | 1,144 | 1,110 | 1,116 | -11 | -1% | 1,434,000 |
| 2013/07/18 | 1,137 | 1,140 | 1,105 | 1,127 | -9 | -0.8% | 1,842,000 |
| 2013/07/17 | 1,123 | 1,137 | 1,123 | 1,136 | +1 | +0.1% | 541,000 |
| 2013/07/16 | 1,138 | 1,150 | 1,123 | 1,135 | +14 | +1.2% | 1,177,000 |
| 2013/07/12 | 1,108 | 1,137 | 1,105 | 1,121 | +13 | +1.2% | 2,015,000 |
| 2013/07/11 | 1,118 | 1,123 | 1,100 | 1,108 | -10 | -0.9% | 1,242,000 |
| 2013/07/10 | 1,144 | 1,145 | 1,109 | 1,118 | -23 | -2% | 1,723,000 |
| 2013/07/09 | 1,124 | 1,145 | 1,114 | 1,141 | +30 | +2.7% | 1,634,000 |
| 2013/07/08 | 1,123 | 1,131 | 1,109 | 1,111 | -2 | -0.2% | 1,164,000 |
| 2013/07/05 | 1,104 | 1,119 | 1,104 | 1,113 | +9 | +0.8% | 1,033,000 |
| 2013/07/04 | 1,099 | 1,107 | 1,094 | 1,104 | -9 | -0.8% | 1,481,000 |
| 2013/07/03 | 1,101 | 1,121 | 1,095 | 1,113 | -21 | -1.9% | 1,789,000 |
| 2013/07/02 | 1,147 | 1,147 | 1,126 | 1,134 | -3 | -0.3% | 1,081,000 |
| 2013/07/01 | 1,120 | 1,138 | 1,102 | 1,137 | +15 | +1.3% | 982,000 |
| 2013/06/28 | 1,067 | 1,124 | 1,067 | 1,122 | +65 | +6.1% | 2,086,000 |
| 2013/06/27 | 1,050 | 1,068 | 1,045 | 1,057 | +15 | +1.4% | 1,944,000 |
| 2013/06/26 | 1,061 | 1,082 | 1,037 | 1,042 | -61 | -5.5% | 1,823,000 |
| 2013/06/25 | 1,105 | 1,110 | 1,085 | 1,103 | -9 | -0.8% | 1,769,000 |
| 2013/06/24 | 1,132 | 1,145 | 1,106 | 1,112 | -20 | -1.8% | 1,571,000 |
| 2013/06/21 | 1,087 | 1,139 | 1,078 | 1,132 | +25 | +2.3% | 4,004,000 |
| 2013/06/20 | 1,108 | 1,124 | 1,103 | 1,107 | -23 | -2% | 1,916,000 |
| 2013/06/19 | 1,130 | 1,150 | 1,104 | 1,130 | +27 | +2.4% | 1,622,000 |
| 2013/06/18 | 1,119 | 1,121 | 1,091 | 1,103 | -21 | -1.9% | 1,516,000 |
| 2013/06/17 | 1,081 | 1,124 | 1,068 | 1,124 | +41 | +3.8% | 1,533,000 |
| 2013/06/14 | 1,072 | 1,116 | 1,072 | 1,083 | +46 | +4.4% | 4,800,000 |
| 2013/06/13 | 1,050 | 1,063 | 1,031 | 1,037 | -30 | -2.8% | 2,873,000 |
| 2013/06/12 | 1,056 | 1,069 | 1,035 | 1,067 | -27 | -2.5% | 2,036,000 |
| 2013/06/11 | 1,055 | 1,104 | 1,048 | 1,094 | +34 | +3.2% | 2,834,000 |
2901～
2950
件表示中 / 3734件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 249,300円 | -3.5% | -11.3% | 2.41% | 22.90倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 139,100円 | +0.9% | +380.2% | 5.61% | 19.15倍 | 1.65倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 250,000円 | +20.9% | +10.6% | 2.64% | 11.82倍 | 1.56倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 411,000円 | +0.1% | -3.4% | 3.89% | 27.94倍 | 1.38倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 157,500円 | +0.6% | +43.3% | 5.08% | 11.04倍 | 0.95倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
